Value of HIF-1αas an independent prognostic indicator in oral squamous cell carcinoma

Expert Review of Molecular Diagnostics

Volumn 11, Issue 2, 2011, Pages 145-147

  Tilakaratne, Wanninayake M ^a,b   Nissanka Jayasuriya, Eranga H ^c  

^a UNIVERSITY OF PERADENIYA   (Sri Lanka)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

HIF 1 ; oral squamous cell carcinoma; prognosis; survival

Indexed keywords

BIOLOGICAL MARKER; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TUMOR MARKER;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; ORAL SQUAMOUS CELL CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TUMOR CELL; TUMOR VOLUME;

EID: 79952954047     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.11.2     Document Type: Article

References (17)

1. Eckert AW, Schutze A, Lautner MHW, Taubert H, Schubert J, Bilkenroth U. HIF-1a is a prognostic marker in OSCC. Int. J. Biol. Markers 25(2), 87-92 (2010).
2. Winter SC, Shah KA, Cheng H et al. The relation between hypoxia-inducible factor (HIF)-1a and HIF-2a expression with anaemia and outcome in surgically treated head and neck cancer. Cancer 107(4), 757-766 (2006). (Pubitemid 44232668)
3. Roh JL, Cho KJ, Kwon GY et al. The prognostic value of hypoxia markers in T2-staged oral tongue cancer. Oral Oncology 45, 63-68 (2009).
4. Rankin EB, Giaccia AJ. Role of hypoxia inducible factors in tumorigenesis. Cell Death Differ. 15, 78-85 (2008).
5. Osada R, Horiuchi A, Kikuchi N et al. Expression of hypoxia-inducible factor 1a, hypoxia-inducible factor 2a, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: Nuclear expression of hypoxia-inducible factor 1a is an independent prognostic factor in ovarian carcinoma. Hum. Pathol. 38, 1310-1320 (2007). (Pubitemid 47247486)
6. Yang QC, Zeng BF, Dong Y, Shi ZM, Jiang ZM, Huang J. Overexpression of hypoxia inducible factor-1a in human osteosarcoma: Correlation with clinic pathological parameters. Jpn. J. Clin. Oncol. 37, 127-134 (2007).
7. Mizokami K, Kakeji Y, Oda S, Maehara Y. Relationship of hypoxia-inducible factor 1a and p21WAF1/CIP1 expression to cell apoptosis and clinical outcome in patients with gastric cancer. World J. Surg. Oncol. 4, 94 (2006).
8. Bangoura G, Liu ZS, Qian Q, Jiang CQ, Yang GF, Jing S. Prognostic significance of HIF-2a/EPAS1 expression in hepatocellular carcinoma. World J. Gastroenterol. 13, 3176-3182 (2007). (Pubitemid 47064579)
9. Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ. Hypoxia-induced tumor angiogenic pathway in head and neck cancer: An in vivo study. Cancer 225, 297-304 (2005). (Pubitemid 40835878)
10. Beasley NJ, Leek R, Alam M et al. Hypoxia-inducible factors HIF-1a and HIF-2a in head and neck cancer: Relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res. 62, 2493-2497 (2002). (Pubitemid 34462724)
11. Tilakaratne WM, Iqbal Z, The MT et al. Upregulation of HIF-1a in malignant transformation of oral submucous fibrosis. J. Oral Pathol. Med. 37, 372-377 (2008). (Pubitemid 351814323)
12. Muñoz-Guerra MF, Fernández-Contreras ME, Moreno AL, Martín ID, Herráez B, Gamallo C. Polymorphisms in the hypoxia inducible factor 1-a and the impact on the prognosis of early stages of oral cancer. Ann. Surg. Oncol. 16, 2351-2358 (2009).
13. Lin PY, Yu CH, Wang JT et al. Expression of hypoxia-inducible factor-1a is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. J. Oral Pathol. Med. 37, 18-25 (2008).
14. Uehara M, Sano K, Ikeda H, Nonaka M, Asahina I. Hypoxia-inducible factor 1a in oral squamous cell carcinoma and its relation to prognosis. Oral Oncology 45, 241-246 (2009).
15. Fillies T, Werkmeister R, van Diest PJ, Brandt B, Joos U, Buerger H. HIF1-a overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor. BMC Cancer 5, 84 (2005).
16. Eckert AW, Lautner MHW, Schütze A et al. Co-expression of HIF1a and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients. J. Oral Pathol. Med. 39, 313-317 (2010).
17. Remmele W, Stegner HE. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 8, 138-140 (1987).